Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine

The candidate malaria vaccine RTS,S has demonstrated 45.7% efficacy over 18 months against all clinical disease in a phase-III field study of African children. RTS,S targets the circumsporozoite protein (CSP), which is expressed on the Plasmodium sporozoite during the pre-erythrocyte stage of its li...

Descripción completa

Detalles Bibliográficos
Autores principales: Moris, Philippe, Jongert, Erik, van der Most, Robbert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791571/
https://www.ncbi.nlm.nih.gov/pubmed/28934066
http://dx.doi.org/10.1080/21645515.2017.1381809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791571/
https://www.ncbi.nlm.nih.gov/pubmed/28934066
http://dx.doi.org/10.1080/21645515.2017.1381809

Ejemplares similares